YMRC
ASTH icon

Yorktown Management & Research Company’s Astrana Health ASTH Stock Holding History

Yorktown Management & Research Company’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-7,100
Closed -$344K – 245
2022
Q1 		$344K Hold
7,100
– – 0.29% 138
2021
Q4 		$522K Hold
7,100
– – 0.35% 115
2021
Q3 		$646K Buy
+7,100
New +$604K 0.49% 54

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AWS
Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Yorktown Management & Research Company's ASTH Position: Q2 2022 in Review

Yorktown Management & Research Company sold out of Astrana Health (ASTH) in Q2 2022, closing a stake of 7,100 shares — an estimated $344K sold.

Yorktown Management & Research Company first reported a position in ASTH in Q3 2021 and held it in 3 quarters. The position peaked at $646K in Q3 2021. 134 funds tracked by Wall St. Rank hold ASTH as of Q2 2022.

  • Yorktown Management & Research Company reported no remaining Astrana Health position as of Q2 2022 after selling out during the quarter.
  • Yorktown Management & Research Company sold 7,100 Astrana Health shares in Q2 2022, an estimated $344K.
  • Yorktown Management & Research Company first reported a position in Astrana Health in Q3 2021 and held it in 3 quarters.
  • Yorktown Management & Research Company's Astrana Health position peaked at $646K in Q3 2021.
  • 134 funds tracked by Wall St. Rank held Astrana Health as of Q2 2022.

Based on Yorktown Management & Research Company's 13F filing for Q2 2022, filed 29 Jul 2022.